Tracon Pharmaceuticals, Inc. — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)

$12.0M

Net Income/Loss (FY2023)

-$3.6M

Total Assets (FY2023)

$10.1M

Total Equity (FY2023)

-$809.0K

Cash Flows from Operating Activities (FY2023)

$3.7M

Source: Tracon Pharmaceuticals, Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.